Differential Expression of Adenosine Receptors in Human Endothelial Cells: Role of A2B Receptors in Angiogenic Factor Regulation

Adenosine has been reported to stimulate or inhibit the release of angiogenic factors depending on the cell type examined. To test the hypothesis that differential expression of adenosine receptor subtypes contributes to endothelial cell heterogeneity, we studied microvascular (HMEC-1) and umbilical vein (HUVEC) human endothelial cells. Based on mRNA level and stimulation of adenylate cyclase, we found that HUVECs preferentially express A2A adenosine receptors and HMEC-1 preferentially express A2B receptors. Neither cells expressed A1 or A3 receptors. The nonselective adenosine agonist 5′-N-ethylcarboxamidoadenosine (NECA) increased expression of interleukin-8 (IL-8), basic fibroblast growth factor (bFGF), and vascular endothelial growth factor (VEGF) in HMEC-1, but had no effect in HUVECs. In contrast, the selective A2A agonist 2-p-(2-carboxyethyl)phenylethylamino-NECA (CGS 21680) had no effect on expression of these angiogenic factors. Cotransfection of each type of adenosine receptors with a luciferase reporter in HMEC-1 showed that A2B receptors, but not A1, A2A, or A3, activated IL-8 and VEGF promoters. These effects were mimicked by constitutively active &agr;Gq, &agr;G12, and &agr;G13, but not &agr;Gs or &agr;Gi1-3. Furthermore, stimulation of phospholipase C indicated coupling of A2B receptors to Gq proteins in HMEC-1. Thus, differential expression of adenosine receptor subtypes contributes to functional heterogeneity of human endothelial cells. A2B receptors, predominantly expressed in human microvascular cells, modulate expression of angiogenic factors via coupling to Gq, and possibly via G12/13.

[1]  T. Voyno-Yasenetskaya,et al.  Constitutive Activation of NF-κB and Secretion of Interleukin-8 Induced by the G Protein-coupled Receptor of Kaposi's Sarcoma-associated Herpesvirus Involve Gα13 and RhoA* , 2001, The Journal of Biological Chemistry.

[2]  I. Biaggioni,et al.  Inhibition of human mast cell activation with the novel selective adenosine A(2B) receptor antagonist 3-isobutyl-8-pyrrolidinoxanthine (IPDX)(2). , 2001, Biochemical pharmacology.

[3]  I. Biaggioni,et al.  Proliferation, migration, and ERK activation in human retinal endothelial cells through A(2B) adenosine receptor stimulation. , 2001, Investigative ophthalmology & visual science.

[4]  A. El‐Naggar,et al.  Expression levels of genes that regulate metastasis and angiogenesis correlate with advanced pathological stage of renal cell carcinoma. , 2001, The American journal of pathology.

[5]  E. Rofstad,et al.  Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts. , 2000, Cancer research.

[6]  M. Sticherling,et al.  Bioactive interleukin-8 is expressed in wounds and enhances wound healing. , 2000, The Journal of surgical research.

[7]  I. Feoktistov,et al.  Adenosine A2A and A2B receptors in cultured human and porcine coronary artery endothelial cells , 2000 .

[8]  I. Clemmensen,et al.  Angiogenic balance in human melanoma: Expression of VEGF, bFGF, IL‐8, PDGF and angiostatin in relation to vascular density of xenografts in vivo , 2000, International journal of cancer.

[9]  F. L. Roudabush,et al.  Down-regulation of vascular endothelial growth factor expression after A(2A) adenosine receptor activation in PC12 pheochromocytoma cells. , 2000, The Journal of pharmacology and experimental therapeutics.

[10]  C. Dinney,et al.  Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[11]  C. Dinney,et al.  Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer. , 2000, Cancer research.

[12]  R. Tarnuzzer,et al.  Adenosine receptor activation induces vascular endothelial growth factor in human retinal endothelial cells. , 1999, Circulation research.

[13]  S. Kobayashi,et al.  Stimulation of Expression for the Adenosine A2A Receptor Gene by Hypoxia in PC12 Cells , 1999, The Journal of Biological Chemistry.

[14]  R. Stone,et al.  A3 adenosine receptors regulate Cl-channels of nonpigmented ciliary epithelial cells. , 1999, American journal of physiology. Cell physiology.

[15]  J. Dobson,et al.  Adenosine A2a receptors increase arterial endothelial cell nitric oxide. , 1998, The Journal of surgical research.

[16]  T. Voyno-Yasenetskaya,et al.  Regulation of Apoptosis by α-Subunits of G12 and G13 Proteins via Apoptosis Signal-regulating Kinase-1* , 1998, The Journal of Biological Chemistry.

[17]  C. Taylor,et al.  Neutrophil-derived 5′-Adenosine Monophosphate Promotes Endothelial Barrier Function via CD73-mediated Conversion to Adenosine and Endothelial A2B Receptor Activation , 1998, The Journal of experimental medicine.

[18]  E. Gabazza,et al.  Adenosine regulates tissue factor expression on endothelial cells. , 1998, Thrombosis research.

[19]  P. de Mazancourt,et al.  Mutant α-Subunit of the G Protein G12 Activates Proliferation and Inhibits Differentiation of 3T3-F442A Preadipocytes. , 1998, Endocrinology.

[20]  I. Biaggioni,et al.  Intravascular source of adenosine during forearm ischemia in humans: implications for reactive hyperemia. , 1998, Hypertension.

[21]  I Biaggioni,et al.  Adenosine A2B receptors. , 1997, Pharmacological reviews.

[22]  V. Sexl,et al.  Stimulation of the Mitogen-activated Protein Kinase via the A2A-Adenosine Receptor in Primary Human Endothelial Cells* , 1997, The Journal of Biological Chemistry.

[23]  P. Casey,et al.  Signalling functions and biochemical properties of pertussis toxin-resistant G-proteins. , 1997, The Biochemical journal.

[24]  L. Aiello,et al.  Adenosine mediates hypoxic induction of vascular endothelial growth factor in retinal pericytes and endothelial cells. , 1996, Investigative ophthalmology & visual science.

[25]  G. Semenza,et al.  Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 , 1996, Molecular and cellular biology.

[26]  N. Ahn,et al.  Gα12 and Gα13 Regulate Extracellular Signal-regulated Kinase and c-Jun Kinase Pathways by Different Mechanisms in COS-7 Cells* , 1996, The Journal of Biological Chemistry.

[27]  M. Goldberg,et al.  Post-transcriptional Regulation of Vascular Endothelial Growth Factor by Hypoxia (*) , 1996, The Journal of Biological Chemistry.

[28]  B. Fredholm,et al.  Functional characterization of adenosine A2 receptors in Jurkat cells and PC12 cells using adenosine receptor agonists , 1996, Naunyn-Schmiedeberg's Archives of Pharmacology.

[29]  W. Buurman,et al.  Adenosine inhibits cytokine release and expression of adhesion molecules by activated human endothelial cells. , 1996, The American journal of physiology.

[30]  Atsushi Namiki,et al.  Hypoxia Induces Vascular Endothelial Growth Factor in Cultured Human Endothelial Cells (*) , 1995, The Journal of Biological Chemistry.

[31]  G. Johnson,et al.  Gα12 and Gα13 Stimulate Rho-dependent Stress Fiber Formation and Focal Adhesion Assembly (*) , 1995, The Journal of Biological Chemistry.

[32]  M. Creager,et al.  Endothelial release of nitric oxide contributes to the vasodilator effect of adenosine in humans. , 1995, Circulation.

[33]  I. Biaggioni,et al.  Adenosine A2b receptors evoke interleukin-8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma. , 1995, The Journal of clinical investigation.

[34]  K. Kage,et al.  Adenosine as an endogenous mediator of hypoxia for induction of vascular endothelial growth factor mRNA in U-937 cells. , 1994, Biochemical and biophysical research communications.

[35]  T. Iwamoto,et al.  IDENTIFICATION OF ADENOSINE A_2 RECEPTORCYCLIC AMP SYSTEM IN HUMAN AORTIC ENDOTHELIAL CELLS , 1994 .

[36]  D. Pinsky,et al.  Hypoxic induction of interleukin-8 gene expression in human endothelial cells. , 1994, The Journal of clinical investigation.

[37]  T. Iwamoto,et al.  Identification of adenosine A2 receptor-cAMP system in human aortic endothelial cells. , 1994, Biochemical and biophysical research communications.

[38]  B. Conklin,et al.  G alpha 13 stimulates Na-H exchange. , 1994, The Journal of biological chemistry.

[39]  I. Biaggioni,et al.  Characterization of adenosine receptors in human erythroleukemia cells and platelets: further evidence for heterogeneity of adenosine A2 receptor subtypes. , 1993, Molecular pharmacology.

[40]  R. Swerlick,et al.  HMEC-1: establishment of an immortalized human microvascular endothelial cell line. , 1992, The Journal of investigative dermatology.

[41]  B. Conklin,et al.  Recombinant Gq alpha. Mutational activation and coupling to receptors and phospholipase C. , 1992, The Journal of biological chemistry.

[42]  H. Bourne,et al.  Mutant α subunits of Gi2 inhibit cyclic AMP accumulation , 1991, Nature.

[43]  P C Sternweis,et al.  Regulation of polyphosphoinositide-specific phospholipase C activity by purified Gq. , 1991, Science.

[44]  E. Kawasaki,et al.  Two G protein oncogenes in human endocrine tumors. , 1990, Science.

[45]  J. Pouysségur,et al.  Deregulation of hamster fibroblast proliferation by mutated ras oncogenes is not mediated by constitutive activation of phosphoinositide‐specific phospholipase C. , 1988, The EMBO journal.

[46]  I. Feoktistov,et al.  Adenosine A(2A) and A(2B) receptors in cultured human and porcine coronary artery endothelial cells. , 2000, American journal of physiology. Heart and circulatory physiology.

[47]  T. Dahms,et al.  Adenosine prevents permeability increase in oxidant-injured endothelial monolayers. , 1998, American journal of physiology. Heart and circulatory physiology.

[48]  W. Schaper,et al.  Role of adenosine in the hypoxic induction of vascular endothelial growth factor in porcine brain derived microvascular endothelial cells. , 1997, Endothelium : journal of endothelial cell research.

[49]  石川 雄治.  Establishment of lipopolysaccharide-dependent nuclear factor κB activation in a cell-free system , 1996 .

[50]  W. Schaper,et al.  Expression of vascular permeability factor/vascular endothelial growth factor in pig cerebral microvascular endothelial cells and its upregulation by adenosine. , 1995, Brain research. Molecular brain research.

[51]  H. Bourne,et al.  Mutant alpha subunits of G12 and G13 proteins induce neoplastic transformation of Rat-1 fibroblasts. , 1994, Oncogene.

[52]  B. Conklin,et al.  Recombinant Gq?: mutational activation and coupling to receptors and phospholipase , 1992 .

[53]  H. Bourne,et al.  Mutant alpha subunits of Gi2 inhibit cyclic AMP accumulation. , 1991, Nature.

[54]  J. Montani,et al.  Vascular development in chick embryos: a possible role for adenosine. , 1989, The American journal of physiology.

[55]  B. F. Becker,et al.  Formation of Adenosine by Vascular Endothelium: a Homeostatic and Antithrombogenic Mechanism? , 1987 .

[56]  B. F. Becker,et al.  Topics and Perspectives in Adenosine Research , 1987, Springer Berlin Heidelberg.